Cargando…

Surgery after Induction Targeted Therapy and Immunotherapy for Lung Cancer

SIMPLE SUMMARY: For patients with locally advanced non-small cell lung cancer (NSCLC) or positive N1 nodes, multimodality treatment is indicated. However, the optimal management of patients presenting with ipsilateral positive mediastinal nodes (N2 disease) has not been determined yet. Different tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allaeys, Toon, Berzenji, Lawek, Van Schil, Paul E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199385/ https://www.ncbi.nlm.nih.gov/pubmed/34073302 http://dx.doi.org/10.3390/cancers13112603

Ejemplares similares

Multimodality Treatment including Surgery Related to the Type of N2 Involvement in Locally Advanced Non-Small Cell Lung Cancer
por: Allaeys, Toon, et al.
Publicado: (2022)

Multimodality treatment of malignant pleural mesothelioma
por: Berzenji, Lawek, et al.
Publicado: (2018)

Safety and Feasibility of Lung Cancer Surgery under the COVID-19 Circumstance
por: Berzenji, Lawek, et al.
Publicado: (2022)

Part-solid tumours: at the border of 2 worlds
por: Van Schil, Paul E, et al.
Publicado: (2021)

Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?
por: Berzenji, Lawek, et al.
Publicado: (2023)

Surgical Management of Stage IIIA Non-Small Cell Lung Cancer
por: Van Schil, Paul E., et al.
Publicado: (2017)

The role of the surgeon in the management of oligometastatic non-small cell lung cancer: a literature review
por: Berzenji, Lawek, et al.
Publicado: (2021)

Update on Pulmonary Ossifications in the Differential Diagnosis of Solitary Pulmonary Nodules
por: Gielis, Jan F., et al.
Publicado: (2021)

Pulmonary metastasectomy in colorectal carcinoma
por: Beckers, Paul, et al.
Publicado: (2021)

Good’s syndrome and COVID-19: case report and literature review
por: Berzenji, Lawek, et al.
Publicado: (2022)

Operable non-small cell lung cancer: induction therapy, adjuvant therapy, or both?
por: Agrafiotis, Apostolos C., et al.
Publicado: (2023)

Conservative Treatment of a Floating Mural Thrombus in the Descending Aorta
por: Goedemé, Johannes, et al.
Publicado: (2021)

Non-small cell lung cancer: the new T1 categories
por: Van Schil, Paul E.
Publicado: (2017)

Lung Cancer Surgery after Neoadjuvant Immunotherapy
por: Stefani, Dirk, et al.
Publicado: (2021)

Lung cancer screening: the preface
por: Snoeckx, Annemiek, et al.
Publicado: (2021)

Targeted therapies and immunotherapy in non-small-cell lung cancer
por: Cortinovis, D, et al.
Publicado: (2016)

Perioperative Targeted Therapy Or Immunotherapy In Non-Small-Cell Lung Cancer
por: Sa, Huanlan, et al.
Publicado: (2019)

Lung Cancer Screening: New Perspective and Challenges in Europe
por: Van Meerbeeck, Jan P., et al.
Publicado: (2022)

Emerging immunotherapy targets in lung cancer
por: Zhu, Hao-Hua, et al.
Publicado: (2020)

Diagnosis and treatment of non-small cell lung cancer: current advances and challenges
por: Diebels, Ian, et al.
Publicado: (2022)

VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment
por: Zhao, Yueshui, et al.
Publicado: (2022)

Novel targeted therapies and immunotherapy for advanced thyroid cancers
por: Naoum, George E., et al.
Publicado: (2018)

Targeted Therapies and Immunotherapies in the Treatment of Esophageal Cancers
por: Barsouk, Adam, et al.
Publicado: (2019)

Targeted Therapy and Immunotherapy for Heterogeneous Breast Cancer
por: Sun, Xiaolu, et al.
Publicado: (2022)

Small-Cell Lung Cancer—An Update on Targeted and Immunotherapies
por: McNamee, Nicholas, et al.
Publicado: (2023)

Sublobar Resection for Early-Stage Lung Cancer: An Oncologically Valid Procedure?
por: Diebels, Ian, et al.
Publicado: (2023)

Frontiers of ctDNA, targeted therapies, and immunotherapy in non-small-cell lung cancer
por: Zhu, Chennianci, et al.
Publicado: (2020)

Advances in targeted therapy and immunotherapy for esophageal cancer
por: Yang, Haiou, et al.
Publicado: (2023)

Immunotherapies and Targeted Therapies in the Treatment of Metastatic Colorectal Cancer
por: Rawla, Prashanth, et al.
Publicado: (2019)

Advancements in Human Breast Cancer Targeted Therapy and Immunotherapy
por: Bou-Dargham, Mayassa J., et al.
Publicado: (2021)

Molecular Targeted Therapy and Immunotherapy for Myelodysplastic Syndrome
por: Lee, Paul, et al.
Publicado: (2021)

Current Landscape of Non-Small Cell Lung Cancer: Epidemiology, Histological Classification, Targeted Therapies, and Immunotherapy
por: Rodak, Olga, et al.
Publicado: (2021)

Therapeutic advances in non‐small cell lung cancer: Focus on clinical development of targeted therapy and immunotherapy
por: Cheng, Yuan, et al.
Publicado: (2021)

The Potential for Cancer Immunotherapy in Targeting Surgery-Induced Natural Killer Cell Dysfunction
por: Market, Marisa, et al.
Publicado: (2018)

Research progress in targeted therapy and immunotherapy for gastric cancer
por: Li, Xuewei, et al.
Publicado: (2022)

Immunotherapy as a targeted therapy in non-small cell lung cancer
por: Rocco, Danilo, et al.
Publicado: (2019)

Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives
por: Zulfiqar, Bilal, et al.
Publicado: (2022)

Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment
por: Kerr, Caroline P., et al.
Publicado: (2022)

Recent advances in immunotherapy and molecular targeted therapy for gastric cancer
por: Yoshinami, Yuri, et al.
Publicado: (2023)

Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
por: Ye, Feng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3i656npunqpbvk880s74u8kbq6